Hi, what are you looking for?
Acelyrin said Thursday that has filed for an initial public offering.
The late stage clinical biopharmaceutical company is offering 30 million shares of common stock at a price of $18 each.
It applied to list its shares on the Nasdaq Global Select Market under the symbol SLRN.
The…
Read the full article here
ĂlĂŠ Asu Good morning, ladies and gentlemen. Welcome to this Thema dedicated to Innovation for Environmental Security. And thank you for joining us remotely...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
Watch full video on YouTube
Watch full video on YouTube
